Carlton Hofferkamp & Jenks Wealth Management LLC acquired a new position in shares of MetLife, Inc. (NYSE:MET – Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 4,482 shares of the financial services provider’s stock, valued at approximately $352,000.
A number of other institutional investors also recently bought and sold shares of MET. Vanguard Group Inc. grew its stake in MetLife by 3.4% in the 1st quarter. Vanguard Group Inc. now owns 59,622,348 shares of the financial services provider’s stock valued at $4,418,612,000 after acquiring an additional 1,974,268 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of MetLife by 22.4% in the second quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider’s stock valued at $378,799,000 after purchasing an additional 988,666 shares during the last quarter. Legal & General Group Plc increased its stake in shares of MetLife by 5.4% during the 2nd quarter. Legal & General Group Plc now owns 5,299,800 shares of the financial services provider’s stock worth $371,993,000 after purchasing an additional 269,246 shares in the last quarter. Envestnet Asset Management Inc. raised its position in shares of MetLife by 3.2% during the 2nd quarter. Envestnet Asset Management Inc. now owns 3,224,930 shares of the financial services provider’s stock worth $226,358,000 after purchasing an additional 100,782 shares during the last quarter. Finally, Bessemer Group Inc. lifted its stake in MetLife by 29.7% in the 1st quarter. Bessemer Group Inc. now owns 2,120,275 shares of the financial services provider’s stock valued at $157,133,000 after buying an additional 485,811 shares in the last quarter. 89.81% of the stock is currently owned by hedge funds and other institutional investors.
MetLife Trading Up 0.5 %
Shares of MET opened at $82.20 on Wednesday. MetLife, Inc. has a twelve month low of $60.26 and a twelve month high of $86.94. The firm has a market capitalization of $56.92 billion, a P/E ratio of 16.57, a price-to-earnings-growth ratio of 0.74 and a beta of 1.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The stock’s fifty day simple moving average is $81.21 and its 200 day simple moving average is $75.38.
MetLife Dividend Announcement
Wall Street Analyst Weigh In
MET has been the subject of a number of analyst reports. Wells Fargo & Company boosted their price target on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. Piper Sandler upped their target price on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a report on Wednesday, October 2nd. Barclays lowered their price target on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a report on Thursday, October 31st. Morgan Stanley reduced their price objective on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research note on Monday, August 19th. Finally, Citigroup boosted their price target on MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a report on Tuesday, July 23rd. Fourteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $88.46.
Get Our Latest Analysis on MET
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- What is the Euro STOXX 50 Index?
- Is Palantir’s AI Edge Enough to Justify Its Price?
- Consumer Staples Stocks, Explained
- 3 Stocks With Special Dividends: Big Payouts for Savvy Investors
- Compound Interest and Why It Matters When Investing
- Is Confluent the Next Big Winner in AI-Powered Data Streaming?
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.